Regulations.gov document
S5(R3) Detection of Reproductive and Developmental Toxicity for Human Pharmaceuticals…
Notice · FDA-2017-D-5138 · posted May 12, 2021
Key facts
| Document ID | FDA-2017-D-5138-0013 |
|---|---|
| Title | S5(R3) Detection of Reproductive and Developmental Toxicity for Human Pharmaceuticals; International Council for Harmonisation; Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2017-D-5138 |
| Posted | May 12, 2021 |
| Federal Register citation | 86 FR 26048 |
| FR document number | 2021-10017 |
| Comment period opens | May 12, 2021 |
| Effective date | May 12, 2021 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: